首页 > 最新文献

Annales De Chirurgie Plastique Esthetique最新文献

英文 中文
[Intraoral lip augmentation]. 【口腔内丰唇术】。
IF 0.5 4区 医学 Q4 SURGERY Pub Date : 2025-12-30 DOI: 10.1016/j.anplas.2025.11.001
V Mitz

Lip augmentation is a procedure frequently performed by cosmetic physicians, as well as cosmetic and reconstructive surgeons. Atrophy of the lips and the surrounding areas or even in the perioral region is often the result of malformations related to insufficient development of structures during embryogenesis, but also the consequence of tissue aging, which affects patients unequally. The general principle of lip and midfacial augmentation involves injections using needles or cannulas that directly puncture the skin at certain strategic points, in order to correctly position the substance intended to increase tissue thickness. One of the adverse consequences of this approach is sometimes excessive augmentation, which occurs even unintentionally, as it is difficult to precisely control the amount to be injected, even with extensive experience. This is why an alternative approach, which is not new, consists of performing these injections, in certain indications, not transcutaneously but rather intraorally. This approach has already been used for around thirty years by a number of surgeons, notably by a French school of aesthetic surgery and medicine. The depth of the injection is therefore of some interest because it allows for less transformation of the face, since the product will be deposited in contact with the periosteum or soft tissues but relatively far from the skin or labial mucosa. In this technical note, the principles of this deep intraoral injection are detailed, and results are presented as well as rare complications.

隆唇是整形医师以及整形和重建外科医生经常进行的手术。嘴唇和周围区域甚至口周区域的萎缩通常是由于胚胎发育过程中结构发育不足导致的畸形,也是组织老化的结果,这对患者的影响是不平等的。嘴唇和面部中部增厚的一般原理包括使用针或套管直接在特定的策略点刺穿皮肤,以便正确定位旨在增加组织厚度的物质。这种方法的一个不良后果是有时会出现过度的增大,这甚至是无意中发生的,因为即使有丰富的经验,也很难精确控制注射量。这就是为什么另一种并不新颖的方法是在某些适应症中进行这些注射,不是经皮注射,而是口服注射。这种方法已经被许多外科医生使用了大约30年,尤其是法国的一个美容外科和医学流派。因此,注射的深度令人感兴趣,因为它允许较少的面部变形,因为产品将沉积在与骨膜或软组织接触的地方,但相对远离皮肤或唇黏膜。在这篇技术笔记中,详细介绍了这种深口内注射的原理,并介绍了结果以及罕见的并发症。
{"title":"[Intraoral lip augmentation].","authors":"V Mitz","doi":"10.1016/j.anplas.2025.11.001","DOIUrl":"https://doi.org/10.1016/j.anplas.2025.11.001","url":null,"abstract":"<p><p>Lip augmentation is a procedure frequently performed by cosmetic physicians, as well as cosmetic and reconstructive surgeons. Atrophy of the lips and the surrounding areas or even in the perioral region is often the result of malformations related to insufficient development of structures during embryogenesis, but also the consequence of tissue aging, which affects patients unequally. The general principle of lip and midfacial augmentation involves injections using needles or cannulas that directly puncture the skin at certain strategic points, in order to correctly position the substance intended to increase tissue thickness. One of the adverse consequences of this approach is sometimes excessive augmentation, which occurs even unintentionally, as it is difficult to precisely control the amount to be injected, even with extensive experience. This is why an alternative approach, which is not new, consists of performing these injections, in certain indications, not transcutaneously but rather intraorally. This approach has already been used for around thirty years by a number of surgeons, notably by a French school of aesthetic surgery and medicine. The depth of the injection is therefore of some interest because it allows for less transformation of the face, since the product will be deposited in contact with the periosteum or soft tissues but relatively far from the skin or labial mucosa. In this technical note, the principles of this deep intraoral injection are detailed, and results are presented as well as rare complications.</p>","PeriodicalId":55512,"journal":{"name":"Annales De Chirurgie Plastique Esthetique","volume":" ","pages":""},"PeriodicalIF":0.5,"publicationDate":"2025-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145879494","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Non-randomized clinical trial in aesthetic dentistry to evaluate marginal bone level in hydrophilic vs. non-hydrophilic implants for mandibular implant overdentures: A split-mouth design. 口腔美学非随机临床试验评估下颌种植覆盖义齿亲水与非亲水种植体的边缘骨水平:开口设计。
IF 0.5 4区 医学 Q4 SURGERY Pub Date : 2025-12-29 DOI: 10.1016/j.anplas.2025.11.002
V Vaz, A Anantharaju, V G Doddawad

Background: Evidence suggests that altering the surface roughness significantly improves implant osseointegration. Enhancing the hydrophilicity of the implants is a similar strategy as hydrophilic surfaces encourage early osseointegration at 14 and 21 days and hasten the bone-healing process after implant placement. Hence, we evaluate and compare the marginal bone level of hydrophilic and non-hydrophilic implants in mandibular implant overdenture.

Methods and material: The study was a non-randomized, prospective split-mouth design with ten patients, each receiving a hydrophilic implant (Group A) and a non-hydrophilic implant (Group B) on opposite sides of the mandibular arch. An implant-supported overdenture was fitted and monitored at baseline, one month, three months, and six months. Marginal bone loss for the early-loaded hydrophilic implant and conventionally loaded non-hydrophilic implant was measured on each side of the mandibular ridge using an XCP holder and RVG radiographs at each interval. Data was obtained and subjected to statistical analysis using the Wilcoxon signed-rank test and Mann-Whitney U test.

Results: Although there was no statistically significant difference in marginal bone loss between the two implants, the hydrophilic implant achieved similar success with a faster healing time compared to the non-hydrophilic implant.

Conclusions: Hydrophilic implants offer a faster-healing alternative to conventional implants for mandibular overdentures.

背景:有证据表明,改变种植体表面粗糙度可显著改善种植体的骨整合。增强种植体的亲水性是一个类似的策略,因为亲水性表面可以促进14和21天的早期骨整合,并加速种植体放置后的骨愈合过程。因此,我们评估和比较下颌种植覆盖义齿亲水种植体和非亲水种植体的边缘骨水平。方法和材料:该研究是非随机的,前瞻性的开口设计,共有10例患者,每个患者在下颌弓的两侧接受亲水种植体(a组)和非亲水种植体(B组)。在基线、1个月、3个月和6个月时安装种植支撑覆盖义齿并进行监测。使用XCP支架和RVG x线片在每个间隔测量早期加载的亲水种植体和常规加载的非亲水种植体在下颌嵴两侧的边缘骨损失。使用Wilcoxon sign -rank检验和Mann-Whitney U检验获得数据并进行统计分析。结果:虽然两种种植体在边缘骨丢失方面没有统计学差异,但亲水种植体与非亲水种植体相比取得了相似的成功,并且愈合时间更快。结论:亲水种植体比传统种植体修复下颌覆盖义齿更快。
{"title":"Non-randomized clinical trial in aesthetic dentistry to evaluate marginal bone level in hydrophilic vs. non-hydrophilic implants for mandibular implant overdentures: A split-mouth design.","authors":"V Vaz, A Anantharaju, V G Doddawad","doi":"10.1016/j.anplas.2025.11.002","DOIUrl":"https://doi.org/10.1016/j.anplas.2025.11.002","url":null,"abstract":"<p><strong>Background: </strong>Evidence suggests that altering the surface roughness significantly improves implant osseointegration. Enhancing the hydrophilicity of the implants is a similar strategy as hydrophilic surfaces encourage early osseointegration at 14 and 21 days and hasten the bone-healing process after implant placement. Hence, we evaluate and compare the marginal bone level of hydrophilic and non-hydrophilic implants in mandibular implant overdenture.</p><p><strong>Methods and material: </strong>The study was a non-randomized, prospective split-mouth design with ten patients, each receiving a hydrophilic implant (Group A) and a non-hydrophilic implant (Group B) on opposite sides of the mandibular arch. An implant-supported overdenture was fitted and monitored at baseline, one month, three months, and six months. Marginal bone loss for the early-loaded hydrophilic implant and conventionally loaded non-hydrophilic implant was measured on each side of the mandibular ridge using an XCP holder and RVG radiographs at each interval. Data was obtained and subjected to statistical analysis using the Wilcoxon signed-rank test and Mann-Whitney U test.</p><p><strong>Results: </strong>Although there was no statistically significant difference in marginal bone loss between the two implants, the hydrophilic implant achieved similar success with a faster healing time compared to the non-hydrophilic implant.</p><p><strong>Conclusions: </strong>Hydrophilic implants offer a faster-healing alternative to conventional implants for mandibular overdentures.</p>","PeriodicalId":55512,"journal":{"name":"Annales De Chirurgie Plastique Esthetique","volume":" ","pages":""},"PeriodicalIF":0.5,"publicationDate":"2025-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145866611","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
State of microsurgery teaching in France in 2025. 2025年法国显微外科教学现状。
IF 0.5 4区 医学 Q4 SURGERY Pub Date : 2025-12-13 DOI: 10.1016/j.anplas.2025.06.015
T Daoulas, P Liverneaux, N Bigorre

Introduction: Microsurgery is becoming increasingly important in many surgical specialities. In France, it is taught as part of university certificates (UC), which are organised in different ways. A previous study carried out in 2014 highlighted several challenges, particularly in terms of finance and structure. This study aims to update this data ten years later to analyse the evolution of microsurgery teaching in France and identify future challenges related to new practices and constraints.

Methods: A descriptive observational survey was performed between January and March 2025 at 28 French university hospitals. The educational referents of the microsurgery university certificates were interviewed using a standardised questionnaire covering teaching methods, hours, assessment methods, registration costs and difficulties encountered. The data collected was compared with that of the 2014 study.

Results: Seventeen centres offered a university certificate in microsurgery, including 14 that already existed in 2014. The average number of hours per year decreased by 24%, while the total number of places offered increased by 86%. Assessment methods remained heterogeneous. The average cost of enrolment in initial training increased by 292 euros. The main challenges identified concerned access to animal models, economic constraints and lack of supervision.

Conclusions: Despite a growing interest in microsurgery training, major disparities persist between university certificates. Standardising programmes, optimising resources and introducing a progressive training pathway could help harmonise practices, while addressing current ethical and logistical issues. We therefore suggest a three-stage model (inert materials, living models, advanced training) to structure learning.

显微外科在许多外科专业中变得越来越重要。在法国,它是作为大学证书(UC)的一部分来教授的,UC的组织方式不同。2014年进行的一项研究强调了一些挑战,特别是在资金和结构方面。本研究旨在十年后更新这些数据,以分析法国显微外科教学的演变,并确定与新实践和限制相关的未来挑战。方法:于2025年1月至3月在法国28所大学医院进行描述性观察性调查。采用标准化问卷对显微外科大学证书的教育对象进行访谈,内容包括教学方法、学时、考核方法、报名费用和遇到的困难。收集的数据与2014年的研究进行了比较。结果:颁发显微外科大学证书的中心17家,其中2014年已有14家。每年的平均学时数减少了24%,而提供的总学额却增加了86%。评估方法仍然不统一。参加初步培训的平均费用增加了292欧元。确定的主要挑战涉及获得动物模型、经济限制和缺乏监督。结论:尽管人们对显微外科培训越来越感兴趣,但各大学证书之间的主要差异仍然存在。标准化项目、优化资源和引入渐进式培训途径可以帮助协调实践,同时解决当前的道德和后勤问题。因此,我们建议采用三阶段模型(惰性材料,活体模型,高级训练)来组织学习。
{"title":"State of microsurgery teaching in France in 2025.","authors":"T Daoulas, P Liverneaux, N Bigorre","doi":"10.1016/j.anplas.2025.06.015","DOIUrl":"https://doi.org/10.1016/j.anplas.2025.06.015","url":null,"abstract":"<p><strong>Introduction: </strong>Microsurgery is becoming increasingly important in many surgical specialities. In France, it is taught as part of university certificates (UC), which are organised in different ways. A previous study carried out in 2014 highlighted several challenges, particularly in terms of finance and structure. This study aims to update this data ten years later to analyse the evolution of microsurgery teaching in France and identify future challenges related to new practices and constraints.</p><p><strong>Methods: </strong>A descriptive observational survey was performed between January and March 2025 at 28 French university hospitals. The educational referents of the microsurgery university certificates were interviewed using a standardised questionnaire covering teaching methods, hours, assessment methods, registration costs and difficulties encountered. The data collected was compared with that of the 2014 study.</p><p><strong>Results: </strong>Seventeen centres offered a university certificate in microsurgery, including 14 that already existed in 2014. The average number of hours per year decreased by 24%, while the total number of places offered increased by 86%. Assessment methods remained heterogeneous. The average cost of enrolment in initial training increased by 292 euros. The main challenges identified concerned access to animal models, economic constraints and lack of supervision.</p><p><strong>Conclusions: </strong>Despite a growing interest in microsurgery training, major disparities persist between university certificates. Standardising programmes, optimising resources and introducing a progressive training pathway could help harmonise practices, while addressing current ethical and logistical issues. We therefore suggest a three-stage model (inert materials, living models, advanced training) to structure learning.</p>","PeriodicalId":55512,"journal":{"name":"Annales De Chirurgie Plastique Esthetique","volume":" ","pages":""},"PeriodicalIF":0.5,"publicationDate":"2025-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145758495","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Two-subunit lower eyelid reconstruction in oncology]. [肿瘤双亚单位下眼睑重建术]。
IF 0.5 4区 医学 Q4 SURGERY Pub Date : 2025-11-24 DOI: 10.1016/j.anplas.2025.10.003
V Commenge, C Berthier, D Gangloff, T Meresse, J Fraisse

To reconstruct a lower eyelid defect involving two aesthetic cutaneous subunits, we propose the use of bilateral upper eyelid dermatochalasis. A homolateral heteropalpebral flap combined with a contralateral upper eyelid skin graft is our first-line option for cutaneous coverage. In the case of full-thickness defects, a composite tarsoconjunctival graft harvested from the three healthy eyelids provides satisfactory and functionally competent tissue reconstruction.

为了重建下眼睑缺损涉及两个审美皮肤亚单位,我们建议使用双侧上眼睑皮肤松弛。同侧异睑瓣结合对侧上睑皮肤移植是我们皮肤覆盖的首选。在全层缺损的情况下,从三个健康的眼睑上摘取的复合睑结膜移植物提供了令人满意和功能正常的组织重建。
{"title":"[Two-subunit lower eyelid reconstruction in oncology].","authors":"V Commenge, C Berthier, D Gangloff, T Meresse, J Fraisse","doi":"10.1016/j.anplas.2025.10.003","DOIUrl":"https://doi.org/10.1016/j.anplas.2025.10.003","url":null,"abstract":"<p><p>To reconstruct a lower eyelid defect involving two aesthetic cutaneous subunits, we propose the use of bilateral upper eyelid dermatochalasis. A homolateral heteropalpebral flap combined with a contralateral upper eyelid skin graft is our first-line option for cutaneous coverage. In the case of full-thickness defects, a composite tarsoconjunctival graft harvested from the three healthy eyelids provides satisfactory and functionally competent tissue reconstruction.</p>","PeriodicalId":55512,"journal":{"name":"Annales De Chirurgie Plastique Esthetique","volume":" ","pages":""},"PeriodicalIF":0.5,"publicationDate":"2025-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145607570","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anatomical reconstruction of the patellar tendon with coverage using a perforator LGAP flap in ballistic trauma: The importance of interdisciplinary collaboration. 在弹道性创伤中应用穿支LGAP皮瓣覆盖髌骨肌腱的解剖重建:跨学科合作的重要性。
IF 0.5 4区 医学 Q4 SURGERY Pub Date : 2025-11-12 DOI: 10.1016/j.anplas.2025.10.004
Pierre Maincourt, Thomas Daoulas, Jimmy Pecheur, Anne-Sophie Henry, Yoann David, Marc-Pierre Henry

Introduction: Ballistic injuries to the knee present a complex reconstructive challenge due to associated bone, tendon, and soft tissue loss. Early coordinated management between orthopedic and plastic surgery teams is essential to optimize functional outcomes.

Case report: We report the case of a 22-year-old male who sustained a Gustilo IIIb open fracture of the proximal tibia following a gunshot wound, with avulsion of the tibial tuberosity and complete patellar tendon rupture. Initial debridement and negative pressure therapy were followed, 48hours later, by anatomical reconstruction of the extensor apparatus using an iliac cortico-cancellous graft in continuity with a gluteal fascia strip, reinforced with pedicled semitendinosus and synthetic tape. Skin coverage was achieved with a pedicled lateral genicular artery perforator (LGAP) flap. Rehabilitation included immobilization in extension and progressive physiotherapy-assisted knee flexion.

Discussion: At 18months, the patient presented complete wound healing, no pain at rest, and partial recovery of function (extension deficit 10°, flexion limited to 80°). The Knee injury and Osteoarthritis Outcome Score (KOOS) was 47. Early pedicled perforator flap coverage provided reliable soft tissue reconstruction while avoiding the complexity of microsurgical free flaps in this anatomically challenging region. The composite reconstruction restored mechanical continuity of the extensor apparatus, enabling stable joint function.

Conclusion: This case illustrates the feasibility and functional benefit of early, coordinated orthopedic-plastic reconstruction for complex ballistic knee injuries, combining bone-tendon reconstruction with local perforator flap coverage. Pedicled perforator flaps are a valuable option for small to medium-sized skin defects in the knee region.

导言:膝关节的弹道性损伤,由于相关的骨、肌腱和软组织的损失,呈现出复杂的重建挑战。骨科和整形外科团队之间的早期协调管理对于优化功能结果至关重要。病例报告:我们报告一例22岁男性,枪伤后胫骨近端Gustilo IIIb开放性骨折,胫骨结节撕脱,髌骨肌腱完全断裂。最初的清创和负压治疗后,48小时后,通过髂皮质松质移植物与臀筋膜带连续,用带蒂半腱肌和合成带加强伸肌器官的解剖重建。采用带蒂膝外侧动脉穿支(LGAP)皮瓣覆盖皮肤。康复包括伸展固定和渐进式物理治疗辅助的膝关节屈曲。讨论:18个月时,患者伤口完全愈合,休息时无疼痛,部分功能恢复(伸展缺损10°,屈曲限制在80°)。膝关节损伤和骨关节炎预后评分(oos)为47分。早期带蒂穿支皮瓣覆盖提供了可靠的软组织重建,同时避免了显微外科自由皮瓣在这一解剖学上具有挑战性的区域的复杂性。复合重建恢复了伸肌装置的机械连续性,使关节功能稳定。结论:本病例说明了骨腱重建结合局部穿支皮瓣覆盖的早期骨科-整形重建治疗复杂弹道膝关节损伤的可行性和功能益处。带蒂穿支皮瓣是一种有价值的选择小到中等皮肤缺损的膝盖区域。
{"title":"Anatomical reconstruction of the patellar tendon with coverage using a perforator LGAP flap in ballistic trauma: The importance of interdisciplinary collaboration.","authors":"Pierre Maincourt, Thomas Daoulas, Jimmy Pecheur, Anne-Sophie Henry, Yoann David, Marc-Pierre Henry","doi":"10.1016/j.anplas.2025.10.004","DOIUrl":"https://doi.org/10.1016/j.anplas.2025.10.004","url":null,"abstract":"<p><strong>Introduction: </strong>Ballistic injuries to the knee present a complex reconstructive challenge due to associated bone, tendon, and soft tissue loss. Early coordinated management between orthopedic and plastic surgery teams is essential to optimize functional outcomes.</p><p><strong>Case report: </strong>We report the case of a 22-year-old male who sustained a Gustilo IIIb open fracture of the proximal tibia following a gunshot wound, with avulsion of the tibial tuberosity and complete patellar tendon rupture. Initial debridement and negative pressure therapy were followed, 48hours later, by anatomical reconstruction of the extensor apparatus using an iliac cortico-cancellous graft in continuity with a gluteal fascia strip, reinforced with pedicled semitendinosus and synthetic tape. Skin coverage was achieved with a pedicled lateral genicular artery perforator (LGAP) flap. Rehabilitation included immobilization in extension and progressive physiotherapy-assisted knee flexion.</p><p><strong>Discussion: </strong>At 18months, the patient presented complete wound healing, no pain at rest, and partial recovery of function (extension deficit 10°, flexion limited to 80°). The Knee injury and Osteoarthritis Outcome Score (KOOS) was 47. Early pedicled perforator flap coverage provided reliable soft tissue reconstruction while avoiding the complexity of microsurgical free flaps in this anatomically challenging region. The composite reconstruction restored mechanical continuity of the extensor apparatus, enabling stable joint function.</p><p><strong>Conclusion: </strong>This case illustrates the feasibility and functional benefit of early, coordinated orthopedic-plastic reconstruction for complex ballistic knee injuries, combining bone-tendon reconstruction with local perforator flap coverage. Pedicled perforator flaps are a valuable option for small to medium-sized skin defects in the knee region.</p>","PeriodicalId":55512,"journal":{"name":"Annales De Chirurgie Plastique Esthetique","volume":" ","pages":""},"PeriodicalIF":0.5,"publicationDate":"2025-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145514824","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prédispositions génétiques aux cancers du sein 乳腺癌的遗传易感性
IF 0.5 4区 医学 Q4 SURGERY Pub Date : 2025-11-01 DOI: 10.1016/j.anplas.2025.05.001
D. Stoppa-Lyonnet , C. Colas
Depuis 30 ans après l’identification des gènes BRCA1 et BRCA2, le panorama des tests de prédisposition aux cancers du sein n’a cessé de se préciser : aujourd’hui le séquençage très haut débit permet l’étude de huit gènes de prédisposition, les indications ne cessent de s’élargir avec comme nouvelle porte d’entrée l’identification d’altérations BRCA1/2 au niveau tumoral dont l’origine est constitutionnelle dans 75 % des cas. Si les tests permettent en cas de facteur de risque identifié une prise en charge adaptée de prévention, de nombreux défis restent à relever : identification de nouveaux gènes de prédisposition ou plutôt validation de gènes candidat dont ATM, détection de nouveaux modes d’inactivation des gènes déjà inscrits dans le diagnostic (délétions à distance, modifications épigénétiques), classification en pathogène ou bénin des variants de signification inconnue, identification et prise en compte dans des modèles multifactoriels de risque des facteurs modificateurs, génétiques ou non. Les patients, leurs apparentés ont joué et continuent de jouer un rôle majeur dans le développement de l’oncogénétique. Nous leur devons des tests de qualité, information, accompagnement et protection.
Over the past 30 years, since the identification of the BRCA1 and BRCA2 genes, the panorama of breast cancer predisposition tests has continued to evolve: today, ultra-high-throughput sequencing enables the study of eight predisposition genes, and indications are constantly expanding, with the new entry point being the identification of BRCA1/2 alterations in tumors, 75% of which are of constitutional origin. While these tests can be used to provide appropriate preventive treatment in cases where risk factors have been identified, many challenges remain to be met: identification of new predisposition genes, or rather validation of candidate genes such as ATM, detection of new modes of inactivation of genes already included in the diagnosis (remote deletions, epigenetic modifications), classification of variants of unknown significance as pathogenic or benign, and identification and inclusion of modifying factors, whether genetic or not, in multifactorial risk models. Patients and their relatives have played, and continue to play, a major role in the development of oncogenetics. We owe them quality tests, information, support and protection.
30年来的BRCA1和BRCA2基因鉴定后,对乳腺癌易感性检测全景一再澄清:自己现在允许研究、高通量测序八个易感基因,不断扩大同作为新标志、前门识别机能宪制层面BRCA1/2原点位于肿瘤中有75%的病例。虽然检测可以在确定的风险因素的情况下提供适当的预防管理,但仍有许多挑战有待克服:确定新易感基因,或者说验证候选人其中ATM基因检测、基因的失活的新模式已经列入(缺失的远程诊断、分类性变异),在贝宁或致病变异的含义不明,多因素模型的识别并体现在是否调节剂、遗传因素的风险。患者及其亲属在肿瘤遗传学的发展中发挥了并将继续发挥重要作用。我们欠他们质量测试、信息、支持和保护。Over the past 30 years since the, the识别BRCA1和BRCA2基因检测乳腺癌predisposition过客has to the概况》的资源:today, ultra-high-throughput sequencing enables the study of游廊predisposition基因里,and are标志可以不断扩大的自在,with the new entry point in tumors BRCA1/2改变的鉴定》,宪法中75% of which are of origin。虽然这些检测可用于在已确定危险因素的情况下提供适当的预防性治疗,但仍需克服许多挑战:of new predisposition基因”的标识,向我验证候选基因,such as ATM detection of new时尚基因失活,学会那里的in the用电(epigenetic remote缺失在内的改动),指定的变异都学会分类,as pathogenic 8金、善意和鉴定与包容of modifying理,如果遗传or not,冠心病risk models。患者及其亲属在肿瘤遗传学的发展中发挥了并将继续发挥重要作用。我们有质量测试,信息,支持和保护。
{"title":"Prédispositions génétiques aux cancers du sein","authors":"D. Stoppa-Lyonnet ,&nbsp;C. Colas","doi":"10.1016/j.anplas.2025.05.001","DOIUrl":"10.1016/j.anplas.2025.05.001","url":null,"abstract":"<div><div>Depuis 30 ans après l’identification des gènes <em>BRCA1</em> et <em>BRCA2</em>, le panorama des tests de prédisposition aux cancers du sein n’a cessé de se préciser : aujourd’hui le séquençage très haut débit permet l’étude de huit gènes de prédisposition, les indications ne cessent de s’élargir avec comme nouvelle porte d’entrée l’identification d’altérations <em>BRCA1/2</em> au niveau tumoral dont l’origine est constitutionnelle dans 75 % des cas. Si les tests permettent en cas de facteur de risque identifié une prise en charge adaptée de prévention, de nombreux défis restent à relever : identification de nouveaux gènes de prédisposition ou plutôt validation de gènes candidat dont <em>ATM</em>, détection de nouveaux modes d’inactivation des gènes déjà inscrits dans le diagnostic (délétions à distance, modifications épigénétiques), classification en pathogène ou bénin des variants de signification inconnue, identification et prise en compte dans des modèles multifactoriels de risque des facteurs modificateurs, génétiques ou non. Les patients, leurs apparentés ont joué et continuent de jouer un rôle majeur dans le développement de l’oncogénétique. Nous leur devons des tests de qualité, information, accompagnement et protection.</div></div><div><div>Over the past 30 years, since the identification of the <em>BRCA1</em> and <em>BRCA2</em> genes, the panorama of breast cancer predisposition tests has continued to evolve: today, ultra-high-throughput sequencing enables the study of eight predisposition genes, and indications are constantly expanding, with the new entry point being the identification of <em>BRCA1/2</em> alterations in tumors, 75% of which are of constitutional origin. While these tests can be used to provide appropriate preventive treatment in cases where risk factors have been identified, many challenges remain to be met: identification of new predisposition genes, or rather validation of candidate genes such as <em>ATM</em>, detection of new modes of inactivation of genes already included in the diagnosis (remote deletions, epigenetic modifications), classification of variants of unknown significance as pathogenic or benign, and identification and inclusion of modifying factors, whether genetic or not, in multifactorial risk models. Patients and their relatives have played, and continue to play, a major role in the development of oncogenetics. We owe them quality tests, information, support and protection.</div></div>","PeriodicalId":55512,"journal":{"name":"Annales De Chirurgie Plastique Esthetique","volume":"70 6","pages":"Pages 609-614"},"PeriodicalIF":0.5,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145486285","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Stratégie thérapeutique des tumeurs des tissus mous et sarcomes périphériques de l’adulte 成人软组织肿瘤和外周肉瘤的治疗策略
IF 0.5 4区 医学 Q4 SURGERY Pub Date : 2025-11-01 DOI: 10.1016/j.anplas.2025.05.008
S. Bonvalot, J.-P. Binder, L. Darrigues, V. Pineau, B. Couturaud
Une masse superficielle ou profonde au niveau des membres et parois est susceptible d’être un sarcome même si elle préexistait de longue date. Elle incite à la prudence car une chirurgie inadaptée péjore le pronostic. Une tumeur superficielle relève d’une échographie : si la tumeur n’est pas parfaitement graisseuse et homogène, une biopsie percutanée est nécessaire. Les tumeurs profondes doivent avoir une IRM suivie d’une biopsie percutanée. Il faut attendre le résultat anatomopathologique définitif qui peut faire appel à de la biologie moléculaire en complément de l’immunohistochimie. S’il s’agit d’un sarcome ou d’une tumeur desmoïde, la stratégie thérapeutique doit être décidée en réunion de concertation pluridisciplinaire spécialisée. Les sarcomes relèvent d’une exérèse large en passant à distance de la lésion afin d’obtenir des marges saines. En France, il existe un réseau de centres spécialisés dans le traitement des sarcomes (NETSARC+).
A superficial or deep mass in the limbs or body walls may be a sarcoma, even if it has been present for a long time. It warrants caution, as inappropriate surgery can worsen the prognosis. A superficial tumor should be evaluated with an ultrasound: if the tumor is not perfectly fatty and homogeneous, a percutaneous biopsy is necessary. Deep tumors require an MRI followed by a percutaneous biopsy. The final histopathological diagnosis must be awaited, which may include molecular biology in addition to immunohistochemistry. If it is a sarcoma or a desmoid tumor, the therapeutic strategy must be decided in a specialized multidisciplinary team meeting. Sarcomas require wide excision, ensuring healthy margins by staying well away from the lesion. In France, there is a network of specialized centers for the treatment of sarcomas (NETSARC+).
四肢和壁上的浅或深肿块可能是肉瘤,即使它已经存在很长时间了。这是一个谨慎的建议,因为不适当的手术会降低预后。浅表肿瘤需要超声检查:如果肿瘤不完全油腻和均匀,则需要经皮活检。深度肿瘤应进行核磁共振成像,然后进行经皮活检。我们必须等待最终的解剖病理学结果,这可能需要分子生物学作为免疫组织化学的补充。如果是肉瘤或干酪样肿瘤,治疗策略必须在多学科专家会议上决定。肉瘤是一种广泛的运动,通过远离病变,以获得健康的边缘。在法国,有一个专门治疗肉瘤的中心网络(NETSARC+)。肉瘤可能发生在四肢或体壁的浅或深肿块,即使它已经存在了很长时间。它保证了安全,因为不适当的手术会使预后恶化。浅表肿瘤应用超声评估:如果肿瘤不完全脂肪和同质性,则需要经皮活检。深肿瘤需要核磁共振成像,然后进行经皮活检。最终的组织病理学诊断必须等待,其中可能包括免疫组织化学以外的分子生物学。如果是肉瘤或脱水肿瘤,治疗策略必须在专门的多学科团队会议上决定。肉瘤需要广泛的切除,通过远离伤口来确保健康的边缘。在法国,有一个治疗肉瘤的专业中心网络(NETSARC+)。
{"title":"Stratégie thérapeutique des tumeurs des tissus mous et sarcomes périphériques de l’adulte","authors":"S. Bonvalot,&nbsp;J.-P. Binder,&nbsp;L. Darrigues,&nbsp;V. Pineau,&nbsp;B. Couturaud","doi":"10.1016/j.anplas.2025.05.008","DOIUrl":"10.1016/j.anplas.2025.05.008","url":null,"abstract":"<div><div>Une masse superficielle ou profonde au niveau des membres et parois est susceptible d’être un sarcome même si elle préexistait de longue date. Elle incite à la prudence car une chirurgie inadaptée péjore le pronostic. Une tumeur superficielle relève d’une échographie : si la tumeur n’est pas parfaitement graisseuse et homogène, une biopsie percutanée est nécessaire. Les tumeurs profondes doivent avoir une IRM suivie d’une biopsie percutanée. Il faut attendre le résultat anatomopathologique définitif qui peut faire appel à de la biologie moléculaire en complément de l’immunohistochimie. S’il s’agit d’un sarcome ou d’une tumeur desmoïde, la stratégie thérapeutique doit être décidée en réunion de concertation pluridisciplinaire spécialisée. Les sarcomes relèvent d’une exérèse large en passant à distance de la lésion afin d’obtenir des marges saines. En France, il existe un réseau de centres spécialisés dans le traitement des sarcomes (NETSARC<sup>+</sup>).</div></div><div><div>A superficial or deep mass in the limbs or body walls may be a sarcoma, even if it has been present for a long time. It warrants caution, as inappropriate surgery can worsen the prognosis. A superficial tumor should be evaluated with an ultrasound: if the tumor is not perfectly fatty and homogeneous, a percutaneous biopsy is necessary. Deep tumors require an MRI followed by a percutaneous biopsy. The final histopathological diagnosis must be awaited, which may include molecular biology in addition to immunohistochemistry. If it is a sarcoma or a desmoid tumor, the therapeutic strategy must be decided in a specialized multidisciplinary team meeting. Sarcomas require wide excision, ensuring healthy margins by staying well away from the lesion. In France, there is a network of specialized centers for the treatment of sarcomas (NETSARC<sup>+</sup>).</div></div>","PeriodicalId":55512,"journal":{"name":"Annales De Chirurgie Plastique Esthetique","volume":"70 6","pages":"Pages 590-597"},"PeriodicalIF":0.5,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145486191","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Le rôle du chirurgien plasticien dans la prise en charge du cancer du sein 整形外科医生在乳腺癌治疗中的作用
IF 0.5 4区 医学 Q4 SURGERY Pub Date : 2025-11-01 DOI: 10.1016/j.anplas.2025.06.004
M. Goutard, A. Glorion, N. Leymarie
<div><div>Le chirurgien plasticien tient une place centrale dans la prise en charge du cancer du sein, de la prévention au suivi post-thérapeutique. La chirurgie esthétique du sein représente une part importante de l’activité de chirurgie plastique en France. Cette pratique place les plasticiens en position privilégiée pour le dépistage précoce du cancer du sein, leur permettant d’identifier les patientes à haut risque et de les orienter vers une surveillance personnalisée. Lors des réunions de concertation pluridisciplinaire, l’expertise du plasticien oriente la stratégie thérapeutique. En évaluant l’impact esthétique et fonctionnel des traitements, il définit avec le chirurgien oncologue une approche chirurgicale qui respecte les impératifs oncologiques tout en limitant les séquelles esthétiques et fonctionnelles. Les techniques d’oncoplastie mammaire se sont imposées dans le traitement conservateur du sein, associant exérèse tumorale et remodelage glandulaire. La reconstruction mammaire fait partie intégrante du traitement et doit être systématiquement proposée en cas de mastectomie. La reconstruction immédiate est discutée selon les caractéristiques histologiques du cancer et les traitements adjuvants prévus. Lors du suivi post-thérapeutique, le chirurgien plasticien finalise la reconstruction mammaire et prend en charge les séquelles des traitements conservateurs par lipofilling ou gestes de symétrisation. Cette prise en charge globale fait du chirurgien plasticien un acteur incontournable de la cancérologie mammaire moderne.</div></div><div><div>Plastic surgeons play a central role in the management of breast cancer, from prevention to post-treatment follow-up. Aesthetic breast surgery accounts for a significant proportion of plastic surgery in France. This practice places plastic surgeons in a privileged position for the early detection of breast cancer, enabling them to identify high-risk patients and steer them towards personalized monitoring. During multidisciplinary consultation meetings, the plastic surgeon's expertise guides the therapeutic strategy. By assessing the aesthetic and functional impact of treatments, he works with the surgical oncologist to define a surgical approach that respects oncological imperatives while limiting aesthetic and functional after-effects. Breast oncoplastic techniques have become an established part of conservative breast treatment, combining tumour removal and glandular remodelling. Breast reconstruction is an integral part of treatment, and must be systematically proposed in the event of mastectomy. Immediate reconstruction is discussed according to the histological characteristics of the cancer and the adjuvant treatments planned. During post-treatment follow-up, the plastic surgeon finalizes the breast reconstruction and manages the after-effects of conservative treatments through lipofilling or symmetrization procedures. This comprehensive approach makes the plastic surgeon a key player in modern
整形外科医生在乳腺癌的管理中扮演着核心角色,从预防到治疗后的随访。在法国,乳房整形手术是整形手术活动的重要组成部分。这种做法使整形医生在乳腺癌的早期检测方面处于有利地位,使他们能够识别高风险患者,并将他们转介到个性化监测。在多学科会议上,整形师的专业知识指导治疗策略。在评估治疗的美学和功能影响时,他与肿瘤学家一起定义了一种既尊重肿瘤学需求,又限制美学和功能后遗症的手术方法。乳房肿瘤成形术是一种结合肿瘤运动和腺体重塑的保守乳房治疗技术。乳房重建是治疗的一个组成部分,必须在乳房切除术的情况下系统地提供。根据癌症的组织学特征和预期的辅助治疗,讨论了立即重建。在治疗后的随访中,整形外科医生完成乳房重建,并通过脂肪填充或对称手势处理保守治疗的后遗症。这种全面的护理使整形外科医生成为现代乳房肿瘤学的重要参与者。整形外科医生在乳腺癌的管理中发挥着核心作用,从预防到治疗后的随访。在英国,美容乳房手术占整形手术的很大比例。这种做法使整形外科医生在早期发现乳腺癌方面处于有利地位,使他们能够识别高风险患者,并指导他们进行个性化监测。在多学科咨询会议上,整形外科医生的专业知识指导治疗策略。通过评估治疗的美学和功能影响,他与外科肿瘤学家合作,定义一种既尊重肿瘤的必要性,又限制美学和功能的后遗症的手术方法。乳房肿瘤成形术已成为保守乳房治疗的既定组成部分,结合肿瘤切除和腺体重塑。乳房重建是治疗的一个组成部分,必须在乳房切除术时系统地提出。根据癌症的组织特征和计划的辅助治疗来讨论立即重建。在治疗后的随访中,整形外科医生完成乳房重建,并通过脂肪填充或对称性程序管理保守治疗的后遗症。这种综合的方法使整形外科医生成为现代乳房肿瘤学的关键参与者。
{"title":"Le rôle du chirurgien plasticien dans la prise en charge du cancer du sein","authors":"M. Goutard,&nbsp;A. Glorion,&nbsp;N. Leymarie","doi":"10.1016/j.anplas.2025.06.004","DOIUrl":"10.1016/j.anplas.2025.06.004","url":null,"abstract":"&lt;div&gt;&lt;div&gt;Le chirurgien plasticien tient une place centrale dans la prise en charge du cancer du sein, de la prévention au suivi post-thérapeutique. La chirurgie esthétique du sein représente une part importante de l’activité de chirurgie plastique en France. Cette pratique place les plasticiens en position privilégiée pour le dépistage précoce du cancer du sein, leur permettant d’identifier les patientes à haut risque et de les orienter vers une surveillance personnalisée. Lors des réunions de concertation pluridisciplinaire, l’expertise du plasticien oriente la stratégie thérapeutique. En évaluant l’impact esthétique et fonctionnel des traitements, il définit avec le chirurgien oncologue une approche chirurgicale qui respecte les impératifs oncologiques tout en limitant les séquelles esthétiques et fonctionnelles. Les techniques d’oncoplastie mammaire se sont imposées dans le traitement conservateur du sein, associant exérèse tumorale et remodelage glandulaire. La reconstruction mammaire fait partie intégrante du traitement et doit être systématiquement proposée en cas de mastectomie. La reconstruction immédiate est discutée selon les caractéristiques histologiques du cancer et les traitements adjuvants prévus. Lors du suivi post-thérapeutique, le chirurgien plasticien finalise la reconstruction mammaire et prend en charge les séquelles des traitements conservateurs par lipofilling ou gestes de symétrisation. Cette prise en charge globale fait du chirurgien plasticien un acteur incontournable de la cancérologie mammaire moderne.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;div&gt;Plastic surgeons play a central role in the management of breast cancer, from prevention to post-treatment follow-up. Aesthetic breast surgery accounts for a significant proportion of plastic surgery in France. This practice places plastic surgeons in a privileged position for the early detection of breast cancer, enabling them to identify high-risk patients and steer them towards personalized monitoring. During multidisciplinary consultation meetings, the plastic surgeon's expertise guides the therapeutic strategy. By assessing the aesthetic and functional impact of treatments, he works with the surgical oncologist to define a surgical approach that respects oncological imperatives while limiting aesthetic and functional after-effects. Breast oncoplastic techniques have become an established part of conservative breast treatment, combining tumour removal and glandular remodelling. Breast reconstruction is an integral part of treatment, and must be systematically proposed in the event of mastectomy. Immediate reconstruction is discussed according to the histological characteristics of the cancer and the adjuvant treatments planned. During post-treatment follow-up, the plastic surgeon finalizes the breast reconstruction and manages the after-effects of conservative treatments through lipofilling or symmetrization procedures. This comprehensive approach makes the plastic surgeon a key player in modern","PeriodicalId":55512,"journal":{"name":"Annales De Chirurgie Plastique Esthetique","volume":"70 6","pages":"Pages 522-527"},"PeriodicalIF":0.5,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145486205","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prothèses et cancer : le lymphome anaplasique à grandes cellules 假肢与癌症:间变性大细胞淋巴瘤
IF 0.5 4区 医学 Q4 SURGERY Pub Date : 2025-11-01 DOI: 10.1016/j.anplas.2025.05.019
R. Bosc
En l’absence de données probantes concernant le diagnostic et la prise en charge du LAGC-AIM causé par les implants mammaires texturés, cet article vise à fournir des recommandations fondées, d’une part sur les données actualisées de la littérature, d’autre part sur l’expérience acquise dans la prise en charge et le traitement des patientes au sein du groupe français d’étude sur le LAGC-AIM. Une recherche a été menée dans les bases de données MEDLINE et Cochrane complétée par des recherches manuelles d’articles pertinents en anglais. Les études portant sur la chirurgie mammaire et le lymphome associé aux implants mammaires ont été incluses. Les articles les plus probants ont été intégrés pour synthétiser les recommandations et déterminer l’incidence, la présentation clinique, les facteurs de risque, les différentes thérapeutiques et la surveillance. Les chirurgiens poseurs de prothèses mammaires doivent prendre conscience des risques spécifiques liés à ces dispositifs médicaux. Les risques à court terme doivent être considérés de manière aussi attentive que les risques à long terme. Les modifications d’un dispositif médical, aussi infimes soient-elles, peuvent engendrer des risques accrus inattendus. Au-delà des procédures habituelles de sécurisation et d’agrément lors de l’introduction sur le marché d’un dispositif médical, la mise en place d’une surveillance appropriée des patientes et les déclarations des évènements indésirables constituent le préalable indispensable à la mise en œuvre des enquêtes d’imputabilité et des éventuelles mesures correctives.
In the absence of evidence regarding the diagnosis and management of LAGC-AIM caused by textured breast implants, this article aims to provide recommendations based, on the one hand, on updated data from the literature, and on the other hand, on the experience gained in the management and treatment of patients within the French LAGC-AIM study group. A search was carried out in the MEDLINE and Cochrane databases, supplemented by manual searches for relevant articles in English. Studies on breast surgery and breast implant-associated lymphoma were included. The most convincing articles were integrated to synthesize recommendations and determine incidence, clinical presentation, risk factors, different therapies and surveillance. Breast implant surgeons need to be aware of the specific risks associated with these medical devices. Short-term risks must be considered as carefully as long-term risks. Modifications to a medical device, no matter how small, can lead to unexpected increased risks. In addition to the usual safety and approval procedures for the market launch of a medical device, appropriate patient monitoring and adverse event reporting are essential prerequisites for the implementation of imputability investigations and any corrective measures.
没有证据就诊断并接管LAGC-AIM隆胸所造成的变形,本文旨在提供建议,一方面是基于对文学的最新数据,另一方面是经验的照顾和治疗的病人在集团内LAGC-AIM上学习法语。对MEDLINE和Cochrane数据库进行了搜索,并手动搜索了相关的英文文章。包括乳房手术和与乳房植入物相关的淋巴瘤的研究。最好的证据被纳入综合建议,并确定发病率、临床表现、风险因素、治疗选择和监测。使用乳房假体的外科医生必须意识到与这些医疗设备相关的特定风险。必须像对待长期风险一样对待短期风险。医疗设备的改变,即使是最小的改变,也可能导致意想不到的风险增加。超出安全标准程序和审批时市场上引入医疗器械”,让病人建立适当监测和不良事件的声明的先决条件是实施问责调查和可能的补救措施。In the集的证据缺乏关于谈话中by the用电and management of LAGC-AIM建立新的植入丰胸,这篇aims to provide建议为基础,on the one hand,更新的data from the文学,and on the other hand, the体验ainsi In the management and of within the French LAGC-AIM study group)的患者治疗。在MEDLINE和Cochrane数据库中进行了搜索,并手动搜索了英文相关文章。包括乳房手术和乳房植入相关淋巴瘤的研究。最令人信服的文章被整合到综合建议中,并确定了发病率、临床表现、风险因素、不同的治疗和监测。乳房植入外科医生需要意识到与这些医疗设备相关的具体风险。短期风险必须与长期风险一样谨慎对待。对医疗设备的修改,无论多么小,都可能导致意想不到的风险增加。除了向市场推出医疗设备的通常安全和批准程序外,适当的患者监测和不良事件报告是实施问责调查和任何纠正措施的基本先决条件。
{"title":"Prothèses et cancer : le lymphome anaplasique à grandes cellules","authors":"R. Bosc","doi":"10.1016/j.anplas.2025.05.019","DOIUrl":"10.1016/j.anplas.2025.05.019","url":null,"abstract":"<div><div>En l’absence de données probantes concernant le diagnostic et la prise en charge du LAGC-AIM causé par les implants mammaires texturés, cet article vise à fournir des recommandations fondées, d’une part sur les données actualisées de la littérature, d’autre part sur l’expérience acquise dans la prise en charge et le traitement des patientes au sein du groupe français d’étude sur le LAGC-AIM. Une recherche a été menée dans les bases de données MEDLINE et Cochrane complétée par des recherches manuelles d’articles pertinents en anglais. Les études portant sur la chirurgie mammaire et le lymphome associé aux implants mammaires ont été incluses. Les articles les plus probants ont été intégrés pour synthétiser les recommandations et déterminer l’incidence, la présentation clinique, les facteurs de risque, les différentes thérapeutiques et la surveillance. Les chirurgiens poseurs de prothèses mammaires doivent prendre conscience des risques spécifiques liés à ces dispositifs médicaux. Les risques à court terme doivent être considérés de manière aussi attentive que les risques à long terme. Les modifications d’un dispositif médical, aussi infimes soient-elles, peuvent engendrer des risques accrus inattendus. Au-delà des procédures habituelles de sécurisation et d’agrément lors de l’introduction sur le marché d’un dispositif médical, la mise en place d’une surveillance appropriée des patientes et les déclarations des évènements indésirables constituent le préalable indispensable à la mise en œuvre des enquêtes d’imputabilité et des éventuelles mesures correctives.</div></div><div><div>In the absence of evidence regarding the diagnosis and management of LAGC-AIM caused by textured breast implants, this article aims to provide recommendations based, on the one hand, on updated data from the literature, and on the other hand, on the experience gained in the management and treatment of patients within the French LAGC-AIM study group. A search was carried out in the MEDLINE and Cochrane databases, supplemented by manual searches for relevant articles in English. Studies on breast surgery and breast implant-associated lymphoma were included. The most convincing articles were integrated to synthesize recommendations and determine incidence, clinical presentation, risk factors, different therapies and surveillance. Breast implant surgeons need to be aware of the specific risks associated with these medical devices. Short-term risks must be considered as carefully as long-term risks. Modifications to a medical device, no matter how small, can lead to unexpected increased risks. In addition to the usual safety and approval procedures for the market launch of a medical device, appropriate patient monitoring and adverse event reporting are essential prerequisites for the implementation of imputability investigations and any corrective measures.</div></div>","PeriodicalId":55512,"journal":{"name":"Annales De Chirurgie Plastique Esthetique","volume":"70 6","pages":"Pages 572-580"},"PeriodicalIF":0.5,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145486213","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mélanome (partie 1) 黑色素瘤(第一部分)
IF 0.5 4区 医学 Q4 SURGERY Pub Date : 2025-11-01 DOI: 10.1016/j.anplas.2025.05.003
C. Lheure
Le mélanome est une tumeur le plus souvent cutanée, développée aux dépens de mélanocytes tumoraux. Son incidence double tous les 10 ans en France. Il existe des facteurs de risque intrinsèques et extrinsèques (exposition UV principalement). En cas de suspicion diagnostique clinique, la prise en charge consistera en une exérèse première sans marge, puis une reprise de marges adaptée à l’indice de Breslow. La réalisation d’un ganglion sentinelle lors de la reprise de marges sera réalisée selon l’indice de Breslow, l’état général et l’âge du patient. Un bilan d’extension sera à réaliser en fonction du stade du mélanome opéré.
Melanoma is a tumor most often found in the skin, developed at the expense of tumor melanocytes. Its incidence doubles every 10 years in France. There are intrinsic and extrinsic risk factors (mainly UV exposure). If a clinical diagnosis is suspected, treatment consists of initial resection without margins, followed by resection of the margins according to the Breslow index. A sentinel lymph node may be included in the revision margin, depending on the Breslow index, the patient's general condition and age. An extension assessment will be carried out depending on the stage of the melanoma operated on.
黑素瘤是一种最常见的皮肤肿瘤,由肿瘤黑素细胞引起。在法国,其发病率每10年翻一番。有内在和外在的危险因素(主要是紫外线照射)。在临床怀疑的情况下,治疗将包括第一次无边际运动,然后根据布雷斯洛指数进行边际恢复。在恢复边缘时,将根据布雷斯洛指数、患者的一般状况和年龄进行前哨神经节的实现。将根据手术的黑色素瘤阶段进行扩展评估。黑素瘤是一种以肿瘤黑素细胞为代价发展的肿瘤,最常出现在皮肤上。在法国,它的发病率每10年翻一番。有内在和外在的危险因素(主要是紫外线照射)。如果怀疑有临床诊断,治疗包括没有边缘的初始切除,然后根据布雷斯洛指数切除边缘。根据布雷斯洛指数、患者的一般状况和年龄,前哨淋巴结可包括在修订边缘。根据黑色素瘤手术的阶段进行扩展评估。
{"title":"Mélanome (partie 1)","authors":"C. Lheure","doi":"10.1016/j.anplas.2025.05.003","DOIUrl":"10.1016/j.anplas.2025.05.003","url":null,"abstract":"<div><div>Le mélanome est une tumeur le plus souvent cutanée, développée aux dépens de mélanocytes tumoraux. Son incidence double tous les 10 ans en France. Il existe des facteurs de risque intrinsèques et extrinsèques (exposition UV principalement). En cas de suspicion diagnostique clinique, la prise en charge consistera en une exérèse première sans marge, puis une reprise de marges adaptée à l’indice de Breslow. La réalisation d’un ganglion sentinelle lors de la reprise de marges sera réalisée selon l’indice de Breslow, l’état général et l’âge du patient. Un bilan d’extension sera à réaliser en fonction du stade du mélanome opéré.</div></div><div><div>Melanoma is a tumor most often found in the skin, developed at the expense of tumor melanocytes. Its incidence doubles every 10 years in France. There are intrinsic and extrinsic risk factors (mainly UV exposure). If a clinical diagnosis is suspected, treatment consists of initial resection without margins, followed by resection of the margins according to the Breslow index. A sentinel lymph node may be included in the revision margin, depending on the Breslow index, the patient's general condition and age. An extension assessment will be carried out depending on the stage of the melanoma operated on.</div></div>","PeriodicalId":55512,"journal":{"name":"Annales De Chirurgie Plastique Esthetique","volume":"70 6","pages":"Pages 461-465"},"PeriodicalIF":0.5,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145486099","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Annales De Chirurgie Plastique Esthetique
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1